Showing results (361-370 of 439) with videos related to

Sort By:
Pageof 44
Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trialArie Pieter Kappetein, Patrick W Serruys, Joseph F Sabik, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Journal of the American College of Cardiology|February 15, 2020
Stent-Related Adverse Events >1 Year After Percutaneous Coronary InterventionMahesh V Madhavan, Ajay J Kirtane, Björn Redfors, et al.
Circulation|October 21, 2020
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced TrialMilton Packer, Stefan D Anker, Javed Butler, et al.
The American Journal of Cardiology|July 6, 2010
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)Ajay J Kirtane, Helen Parise, Roxana Mehran, et al.
ESC Heart Failure|February 19, 2026
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER studyDennis M McNamara, Leslie T Cooper, Matthias G Friedrich, et al.
American Heart Journal|December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT studyUsman Baber, George Dangas, David J Cohen, et al.
Health Technology Assessment (Winchester, England)|March 15, 2005
Issues in data monitoring and interim analysis of trialsA M Grant, D G Altman, A B Babiker, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
Pageof 44